🕒 Tuesday 26 August 2025 Tue, 26 Aug 2025

Holista Colltech has inked a binding supply and development agreement with US-based Regenerex Pharma to exclusively supply proprietary ovine collagen for advanced wound care products, targeting the lucrative US market initially with plans for global expansion.

Noumi Limited reported a 13% rise in adjusted operating EBITDA for FY25, driven by strong growth in its plant-based milks and dairy segments. The company has resolved legacy litigation issues and is now focused on navigating the $610 million convertible note maturity due in 2027.

Noumi Limited reported modest revenue growth and a significant rise in adjusted EBITDA for FY25, driven by its Milklab brand’s strong performance and a continued turnaround in its Dairy & Nutritionals segment. The company also resolved all legacy legal issues, positioning itself for future growth.

Noumi Limited has posted a significant $150 million loss for the year ending June 2025, driven by non-cash charges and raising questions about its financial stability.

Askari Metals is gearing up for a pivotal shareholder meeting to approve its Ethiopian gold and copper acquisition, while restructuring debt and expanding European investor outreach.

Acusensus Limited reported a robust FY25 with 20% revenue growth and a significant 84% jump in total contract value, setting the stage for an ambitious FY26 forecast of up to 41% revenue increase.

Acusensus Limited reported a 20% increase in revenue to $59.35 million for FY25, driven by new and expanded contracts across Australia, New Zealand, the US, and the UK. However, net losses widened by 72.3%, reflecting higher operating expenses and ongoing litigation costs.

Austin Engineering Limited reported a robust 22.2% increase in revenue for FY25, alongside a mixed earnings performance and fully franked dividends.

Robex Resources confirms steady progress at its Kiniero Gold Project in Guinea, maintaining schedule and budget for first gold production in late 2025. Key construction milestones and drilling activities highlight the project’s momentum.

Firebrick Pharma has closed a $1.4 million placement to fund expansion of its Nasodine nasal spray in key international markets and advance new product development.

Vulcan Steel is set to acquire Roofing Industries for NZ$88 million, marking a strategic entry into New Zealand’s steel roofing market. The deal is backed by an A$87 million equity raise, positioning Vulcan for growth in building materials.

Firebrick Pharma has secured an exclusive licensing agreement with Innorini Pte Ltd to distribute Nasodine products across Singapore, Malaysia, Brunei, and Mauritius, aiming to reduce marketing expenses and broaden market access.

Vulcan Steel Limited reported a 10.9% revenue decline in FY25 alongside a 24.1% drop in adjusted EBITDA, while announcing a fully underwritten NZ$96 million equity raise to fund the acquisition of Roofing Industries Limited. The deal marks Vulcan’s strategic entry into the New Zealand steel roofing and cladding market with expected earnings accretion and no change to its dividend policy.

Vulcan Steel reported a sharp decline in profits for FY25 amid challenging economic conditions but managed to reduce net debt and push forward its hybrid site strategy.

Ora Banda Mining Ltd delivered a standout FY25 with net profit soaring 575% to $186 million, driven by record gold production and successful underground mine expansions. The company sets ambitious FY26 targets amid strong operational momentum.

Veris Limited has reported a significant turnaround in FY25, posting a $2 million profit before tax on $97.2 million revenue, driven by growth in digital and spatial advisory services and strategic acquisitions.

Veris Limited has returned to profitability in FY25, driven by strong growth in its digital and spatial advisory services, while declaring its first dividend in years and strengthening its cash position.

Imricor Medical Systems reports significant regulatory approvals and clinical trial progress, positioning itself as a disruptive force in the growing electrophysiology market. With a strengthened commercial pipeline and solid cash reserves, the company is poised for a pivotal growth phase.

Veris Limited has reported a significant financial turnaround for the year ended June 2025, returning to profitability and boosting earnings, while strategically acquiring Spatial Vision to broaden its geospatial services across Australia.

Imricor Medical Systems reported a sharp 52% revenue decline and a 92% increase in net loss for H1 2025, offset by a $42.8 million equity raise boosting liquidity. The company is investing heavily in European sales and clinical trials while pursuing FDA approval.

Critica Limited has dispatched an upgraded composite concentrate from its Jupiter Project to ANSTO for independent hydrometallurgical testing, aiming to produce a Mixed Rare Earth Carbonate (MREC). Complementary assessments by Minutech will help optimise processing routes and support upcoming feasibility studies.

Miramar Resources has partnered with Sumitomo Metal Mining Oceania in a multi-million-dollar joint venture to explore for large-scale nickel-copper-platinum group element deposits at the Bangemall Projects in Western Australia.

PRL Global Ltd reported a robust 16.8% revenue increase to $1.48 billion for the year ended June 2025, yet net profit after tax plunged by over 50%, prompting a cautious dividend outlook.

West African Resources has reported a robust first half of 2025, delivering A$215 million in net profit after tax on the back of strong gold production and sales.